General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0KBOPT
ADC Name
wO2024239281A1 C237
Synonyms
WO2024239281A1 C237
   Click to Show/Hide
Organization
HANGZHOU DAC BIOTECH CO., LTD
Drug Status
Investigative
Drug-to-Antibody Ratio
7.6
Structure
Antibody Name
Vandortuzumab
 Antibody Info 
Antigen Name
Metalloreductase STEAP1 (STEAP1)
 Antigen Info 
Payload Name
Exatecan-PEG2-Ala
 Payload Info 
Therapeutic Target
DNA topoisomerase I (TOP1)
 Target Info 
Linker Name
Maleimide-PEG-L-Valine linker
 Linker Info 
Conjugate Type
Random conjugation through reduced inter-chain cysteines.
Combination Type
(7S,10S,13S,70S,74S)-1- ((S)-4,11-diethyl-8-fluoro-4-hydroxy-3,14- dioxo-3,4,12,14-tetrahydro-1H-pyrano [3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy)-13- (4- (2,5- dioxo-2,5-dihydro-1H-pyrrol-1-yl)butanamido)-10-isopropyl-7-methyl-6,9,12,19,35,51,67,72-octaoxo-3,22,25,28,31,38,41,44,47,54,57,60,63-tridecaoxa-5,8,11,18,34,50,66,71,73-nonaazahexaheptacontane-70,74,76-tricarboxylic acid
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 3 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal inhibitory Concentration (lC50) 
0.048
nM
Undisclosed
Prostate carcinoma
Half Maximal inhibitory Concentration (lC50) 
0.065
nM
CVCL_4784
Prostate carcinoma
Half Maximal inhibitory Concentration (lC50) 
5.23
nM
CVCL_1045
Prostate carcinoma
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 3 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) 0.048 nM High Steap1 and PSMA expression (Steapl and PSMA +++)
Method Description
PC-3-4H7 cell is both Steap1and PSMA antigen high express cells. To run the assay,the cells (180 ul,6000cells)were added to each well in a 96-well plate and incubated for 24 hours at 37°C with 5%CO 2. Next,the cells were treated with test compounds (20ul)at various concentrations in appropriate cell culture medium (total volume,0.2 mL).The control wells contain cells and the medium but lack the test compounds.The plates were incubated for 120 hours at 37°C with 5%CO 2.MTT (5 mg/mL)was then added to the wells (20ul)and the plates were incubated for 1.5 hr at 37°C.The medium was carefully removed and DMSO (180ul)was added afterward.After it was shaken for 15min, the absorbance was measured at 490 nm and 570 nm with a reference filter of 620 nm.The inhibition% was calculated according to the following equation:inhibition%=[1- (assay-blank)/ (control-blank)]× 100.

   Click to Show/Hide
In Vitro Model Prostate carcinoma PC-3-4H7 cells Homo sapiens
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) 0.065 nM High Steap1 and PSMA expression (Steapl and PSMA +++)
Method Description
C4-2B is both Steap1 and PSMA antigen high express cells.To run the assay,the cells (180 ul,6000cells)were added to each well in a 96-well plate and incubated for 24 hours at 37°C with 5%CO 2. Next,the cells were treated with test compounds (20ul)at various concentrations in appropriate cell culture medium (total volume,0.2 mL).The control wells contain cells and the medium but lack the test compounds.The plates were incubated for 120 hours at 37°C with 5%CO 2.MTT (5 mg/mL)was then added to the wells (20ul)and the plates were incubated for 1.5 hr at 37°C.The medium was carefully removed and DMSO (180ul)was added afterward.After it was shaken for 15min, the absorbance was measured at 490 nm and 570 nm with a reference filter of 620 nm.The inhibition% was calculated according to the following equation:inhibition%=[1- (assay-blank)/ (control-blank)]× 100.

   Click to Show/Hide
In Vitro Model Prostate carcinoma C4-2B cells CVCL_4784
Experiment 3 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) 5.23 nM Low Steap1 and PSMA expression (Steap1 and PSMA+)
Method Description
22RV1 is both Steapl and PSMA antigen low express cells.To run the assay,the cells (180 ul,6000cells)were added to each well in a 96-well plate and incubated for 24 hours at 37°C with 5%CO 2. Next,the cells were treated with test compounds (20ul)at various concentrations in appropriate cell culture medium (total volume,0.2 mL).The control wells contain cells and the medium but lack the test compounds.The plates were incubated for 120 hours at 37°C with 5%CO 2.MTT (5 mg/mL)was then added to the wells (20ul)and the plates were incubated for 1.5 hr at 37°C.The medium was carefully removed and DMSO (180ul)was added afterward.After it was shaken for 15min, the absorbance was measured at 490 nm and 570 nm with a reference filter of 620 nm.The inhibition% was calculated according to the following equation:inhibition%=[1- (assay-blank)/ (control-blank)]× 100.

   Click to Show/Hide
In Vitro Model Prostate carcinoma 22RV1 cells CVCL_1045
References
Ref 1 Targeted treatment of prostate cancers and other tumors by an antibody-drug conjugate